{"id":"NCT00441441","sponsor":"GlaxoSmithKline","briefTitle":"A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma","officialTitle":"A Randomized, Double-blind, Parallel Group Study Evaluating the Safety of Fluticasone Propionate/Salmeterol 100/50mcg HFA (2 Inhalations of 50/25mcg) Twice Daily Compared With Fluticasone Propionate 100mcg HFA (2 Inhalations of 50mcg) Twice Daily in Subjects 4-11 Years of Age With Persistent Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-02","primaryCompletion":"2008-01","completion":"2008-01","firstPosted":"2007-03-01","resultsPosted":"2010-09-23","lastUpdate":"2016-12-16"},"enrollment":351,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"fluticasone propionate","otherNames":[]},{"type":"DRUG","name":"fluticasone propionate/salmeterol","otherNames":[]}],"arms":[{"label":"Fluticasone propionate/salmeterol 100/50 HFA","type":"EXPERIMENTAL"},{"label":"Fluticasone propionate 100mcg HFA","type":"EXPERIMENTAL"}],"summary":"This study is to assess the safety of an investigational drug in children 4 to 11 years of age who have asthma. The subjects will attend 7 clinic visits, of which up to 3 will be in the morning, and have lung function tests performed.","primaryOutcome":{"measure":"Possible Drug-Related Adverse Events","timeFrame":"Treatment period (weeks 1-12) and Post Treatment (â‰¥1 day after last time study drug)","effectByArm":[{"arm":"Fluticasone Propionate/Salmeterol HFA","deltaMin":13,"sd":null},{"arm":"Fluticasone Propionate HFA","deltaMin":16,"sd":null}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":55,"countries":["United States","Australia","Canada","Chile","Costa Rica","Germany","Latvia","Lithuania","Mexico","Peru","Poland","Russia","Spain"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":173},"commonTop":["Headache","Nasopharyngitis","Upper Respiratory Tract Infection","Pyrexia","Pharyngitis"]}}